In an in vivo study, temsirolimus was shown to block signal transduction of mTOR pathway to decrease VEGF production, but failed to sensitize HNSCC to radiation by clonogenic assay. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.